Gene Therapy Study in Severe Hemophilia a Patients with Antibodies Against AAV5

You're leaving the BioMarin Clinical Trials website.

This will take you to BioMarin.com, our global corporate website. Some of the information on BioMarin.com is intended for U.S. audiences only.

Links to sites outside of this website are provided as a resource to the viewer. BioMarin accepts no responsibility for the content of linked sites.